metformin and sibutramine

metformin has been researched along with sibutramine in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's16 (61.54)29.6817
2010's10 (38.46)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ertorer, EM; Gokcel, A; Guvener, N; Karakose, H; Tanaci, N; Tutuncu, NB1
BascilTutuncu, N; Gokcel, A; Gumurdulu, Y; Guvener, N; Karakose, H; Melek Ertorer, E; Tanaci, N1
Sanders, TA; Taylor, D; Werneke, U1
McNulty, SJ; Ur, E; Williams, G1
Kumar, S; Peter, P1
Aucott, L; Avenell, A; Broom, J; Brown, TJ; Campbell, MK; Grant, AM; Jung, RT; Poobalan, A; Smith, WC; Stearns, SC1
Dravecka, I; Kraus, V; Lazurova, I; Petrovicova, J1
Alisky, JM1
Cesarino, EJ; de Almeida, CA; de Carvalho, D; Guimarães, C; Iucif Júnior, N; Pereira, LR; Queiroz, RH1
Desilets, AR; Dunican, KC; Montalbano, JK1
Al-Zaman, Y; Aylwin, S1
Baptista, T; Beaulieu, S; de Baptista, EA; El Fakih, Y; Galeazzi, T; Rangel, N; Uzcátegui, E1
Aronne, LJ; Neff, LM1
Barnett, A; Rahim, A; Samat, A1
Ciccarelli, L; Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Gravina, A; Maffioli, P; Mereu, R; Piccinni, MN; Salvadeo, SA1
Uli, NK; Wald, AB1
Akbas, H; Coban, E; Eray, E; Ozdem, S; Sari, R1
Delkos, D; Dinas, K; Kalaitzakis, E; Kandaraki, EA; Katsikis, I; Koiou, E; Panidis, D; Tziomalos, K1
Delkos, D; Kalaitzakis, E; Kandaraki, EA; Katsikis, I; Koiou, E; Panidis, D; Tziomalos, K; Vosnakis, C1
Armstrong, SC; Dolinsky, DH; Kinra, S1
Kautzky-Willer, A; Lemmens-Gruber, R1
Andersson, C; Caterson, I; Coutinho, W; Finer, N; Ghotbi, AA; James, WP; Køber, L; Sharma, AM; Torp-Pedersen, C; Van Gaal, LF1
Atkinson, G; Baur, L; Corpeleijn, E; Ells, LJ; Finer, N; Mead, E; Metzendorf, MI; O'Malley, C; Richter, B1
Ahmed, AT; Almasri, J; Alsawas, M; Asi, N; Farah, W; Mohammed, K; Murad, MH; Prokop, LJ; Rajjo, T1

Reviews

12 review(s) available for metformin and sibutramine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Options for pharmacological management of obesity in patients treated with atypical antipsychotics.
    International clinical psychopharmacology, 2002, Volume: 17, Issue:4

    Topics: Amantadine; Antipsychotic Agents; Cimetidine; Cyclobutanes; Fluoxetine; Fructose; Humans; Lactones; Metformin; Nizatidine; Obesity; Orlistat; Topiramate; Weight Gain

2002
Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Health technology assessment (Winchester, England), 2004, Volume: 8, Issue:21

    Topics: Anti-Obesity Agents; Behavior Therapy; Caloric Restriction; Cost-Benefit Analysis; Cyclobutanes; Diet, Fat-Restricted; Humans; Hypoglycemic Agents; Lactones; Markov Chains; Metformin; Obesity; Orlistat; Physical Fitness; Randomized Controlled Trials as Topic; Risk Factors

2004
Pharmacotherapeutic options for overweight adolescents.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:9

    Topics: Adolescent; Anti-Obesity Agents; Clinical Trials as Topic; Cyclobutanes; Humans; Hypoglycemic Agents; Lactones; Metformin; Obesity; Orlistat; Overweight

2007
Emerging concepts in the medical and surgical treatment of obesity.
    Frontiers of hormone research, 2008, Volume: 36

    Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide

2008
Pharmacotherapy for obesity.
    Current atherosclerosis reports, 2007, Volume: 9, Issue:6

    Topics: Amyloid; Anti-Obesity Agents; Appetite Depressants; Body Weight; Chronic Disease; Comorbidity; Cyclobutanes; Exenatide; Gastrointestinal Hormones; Humans; Islet Amyloid Polypeptide; Lactones; Leptin; Metformin; Obesity; Orlistat; Peptides; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Rimonabant; Venoms

2007
Pharmacotherapy for obesity in menopausal women.
    Menopause international, 2008, Volume: 14, Issue:2

    Topics: Anti-Obesity Agents; Bariatric Surgery; Cyclobutanes; Diabetes Mellitus, Type 2; Exenatide; Female; Humans; Hypoglycemic Agents; Lactones; Menopause; Metformin; Obesity; Orlistat; Peptides; Piperidines; Pyrazoles; Rimonabant; Risk Factors; Venoms

2008
Pharmacotherapy in pediatric obesity: current agents and future directions.
    Reviews in endocrine & metabolic disorders, 2009, Volume: 10, Issue:3

    Topics: Anti-Obesity Agents; Child; Cyclobutanes; Drug Therapy; Humans; Metformin; Obesity

2009
The clinical treatment of childhood obesity.
    Indian journal of pediatrics, 2013, Volume: 80 Suppl 1

    Topics: Adolescent; Bariatric Surgery; Behavior Therapy; Child; Child, Preschool; Combined Modality Therapy; Cooperative Behavior; Cyclobutanes; Energy Intake; Evidence-Based Medicine; Humans; Infant; Interdisciplinary Communication; Lactones; Life Style; Metformin; Motor Activity; Orlistat; Overweight; Pediatric Obesity; Pediatrics; Physician's Role; Practice Guidelines as Topic; Risk Factors; Young Adult

2013
Obesity and diabetes.
    Handbook of experimental pharmacology, 2012, Issue:214

    Topics: Animals; Cyclobutanes; Diabetes Mellitus; Female; Humans; Incretins; Insulin; Lactones; Male; Metformin; Obesity; Orlistat; Piperidines; Pyrazoles; Rimonabant; Sex Characteristics; Sulfonylurea Compounds

2012
Drug interventions for the treatment of obesity in children and adolescents.
    The Cochrane database of systematic reviews, 2016, Nov-29, Volume: 11

    Topics: Adolescent; Anti-Obesity Agents; Body Mass Index; Child; Cyclobutanes; Fluoxetine; Humans; Lactones; Metformin; Orlistat; Pediatric Obesity; Randomized Controlled Trials as Topic

2016
Treatment of Pediatric Obesity: An Umbrella Systematic Review.
    The Journal of clinical endocrinology and metabolism, 2017, 03-01, Volume: 102, Issue:3

    Topics: Adolescent; Anti-Obesity Agents; Appetite Depressants; Bariatric Surgery; Behavior Therapy; Blood Glucose; Blood Pressure; Body Mass Index; Child; Cholesterol, HDL; Cyclobutanes; Diet Therapy; Diet, Carbohydrate-Restricted; Diet, Fat-Restricted; Exercise; Exercise Therapy; Gastrectomy; Gastric Bypass; Humans; Hypoglycemic Agents; Lactones; Metformin; Orlistat; Patient Education as Topic; Pediatric Obesity; Treatment Outcome; Triglycerides; Waist Circumference

2017

Trials

10 trial(s) available for metformin and sibutramine

ArticleYear
Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control.
    Diabetes care, 2001, Volume: 24, Issue:11

    Topics: Appetite Depressants; Blood Glucose; Cholesterol; Cyclobutanes; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glipizide; Humans; Hypoglycemic Agents; Insulin; Metformin; Obesity; Placebos; Sulfonylurea Compounds; Triglycerides; Weight Loss

2001
Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity.
    Diabetes, obesity & metabolism, 2002, Volume: 4, Issue:1

    Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Blood Glucose; Body Mass Index; Body Weight; Cyclobutanes; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Lactones; Metformin; Obesity; Orlistat; Postprandial Period; Safety; Treatment Outcome; Weight Loss

2002
A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin.
    Diabetes care, 2003, Volume: 26, Issue:1

    Topics: Appetite Depressants; Blood Glucose; Blood Pressure; Body Weight; Cyclobutanes; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Heart Rate; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Obesity; Treatment Outcome

2003
Metformin versus sibutramine in the treatment of hyperinsulinemia in chronically anovulating women.
    Bratislavske lekarske listy, 2004, Volume: 105, Issue:5-6

    Topics: Adult; Anovulation; Appetite Depressants; Body Mass Index; Chronic Disease; Cyclobutanes; Diet, Reducing; Exercise Therapy; Female; Hormones; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Weight Loss

2004
Tolerability and effectiveness of fluoxetine, metformin and sibutramine in reducing anthropometric and metabolic parameters in obese patients.
    Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:6

    Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Appetite Depressants; Cholesterol; Combined Modality Therapy; Cyclobutanes; Fluoxetine; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Multicenter Studies as Topic; Obesity; Placebos; Single-Blind Method

2006
Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study.
    Psychiatry research, 2008, May-30, Volume: 159, Issue:1-2

    Topics: Adult; Antipsychotic Agents; Appetite Depressants; Benzodiazepines; Body Mass Index; Chronic Disease; Cyclobutanes; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Middle Aged; Obesity; Olanzapine; Pilot Projects; Placebos; Schizophrenia; Schizophrenic Psychology; Waist-Hip Ratio; Weight Gain; Weight Loss

2008
Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
    Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:5

    Topics: Appetite Depressants; Blood Glucose; Blood Pressure; Cyclobutanes; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Obesity; Pioglitazone; Thiazolidinediones; Treatment Outcome; Triglycerides

2009
Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women.
    Clinical and experimental medicine, 2010, Volume: 10, Issue:3

    Topics: Adult; Appetite Depressants; C-Reactive Protein; Cyclobutanes; Drug Therapy, Combination; Female; Humans; Insulin Resistance; Leptin; Metformin; Middle Aged; Obesity; Treatment Outcome; Weight Loss

2010
Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2012, Volume: 28, Issue:1

    Topics: Acute-Phase Proteins; Adolescent; Adult; Anti-Obesity Agents; Caloric Restriction; Combined Modality Therapy; Cyclobutanes; Down-Regulation; Exercise Therapy; Female; Humans; Lactones; Lipocalin-2; Lipocalins; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Proto-Oncogene Proteins; Weight Loss; Young Adult

2012
Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial.
    Diabetes care, 2013, Volume: 36, Issue:11

    Topics: Aged; Cardiovascular Diseases; Clinical Protocols; Cyclobutanes; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Myocardial Infarction; Obesity; Overweight; Risk; Stroke; Sulfonylurea Compounds

2013

Other Studies

4 other study(ies) available for metformin and sibutramine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Management of the overweight patient with Type 2 diabetes.
    Diabetic medicine : a journal of the British Diabetic Association, 2003, Volume: 20 Suppl 4

    Topics: Anti-Obesity Agents; Cyclobutanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Lactones; Metformin; Middle Aged; Obesity; Orlistat; Selective Serotonin Reuptake Inhibitors; Sulfonylurea Compounds

2003
Phentermine, sibutramine and metformin could be used for the prevention and treatment of steroid-induced weight gain.
    Medical hypotheses, 2007, Volume: 68, Issue:2

    Topics: Adrenergic Agents; Appetite Depressants; Cyclobutanes; Humans; Hypoglycemic Agents; Metformin; Phentermine; Steroids; Weight Gain

2007
The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome.
    Endocrine journal, 2011, Volume: 58, Issue:4

    Topics: Adolescent; Adult; Body Mass Index; Cyclobutanes; Diet, Reducing; Female; Humans; Lactones; Metformin; Orlistat; Overweight; Polycystic Ovary Syndrome; Serpins; Weight Loss

2011